Asset and Capital Structure of the Bayer Group (XLS:) Download Bayer Group Summary Statements of Financial Position Dec. 31, 2016 Dec. 31, 2017 Change € million € million % Noncurrent assets 51,791 45,014 −13.1 Assets held for sale 10 2,081 . Other current assets 30,437 27,992 −8.0 Current assets 30,447 30,073 −1.2 Total assets 82,238 75,087 −8.7 Equity 31,897 36,861 +15.6 Noncurrent liabilities 31,804 24,633 −22.5 Current liabilities 18,537 13,482 −27.3 Liabilities directly related to assets held for sale . 111 . Total current liabilities 18,537 13,593 −26.7 Liabilities 50,341 38,226 −24.1 Total equity and liabilities 82,238 75,087 −8.7 Substantial increase in equity, while total assets decline Total Assets € billion Total assets as of December 31, 2017, declined by €7.2 billion to €75.1 billion, mainly as a result of the deconsolidation of Covestro. As part of that deconsolidation, assets of €11.2 billion were derecognized in the respective line items in the statements of financial position. At the same time, the remaining investment in the Covestro Group was recognized at its fair value of €3.6 billion. Noncurrent assets decreased by €6.8 billion to €45.0 billion. Total current assets declined by €0.4 billion to €30.1 billion. The assets held for sale in connection with the planned acquisition of Monsanto increased by €2.1 billion. Equity rose by €5.0 billion compared with December 31, 2016, to €36.9 billion. The income after income taxes of €8.1 billion had a positive effect. Currency effects recognized outside profit and loss reduced equity by €2.2 billion, and the dividend payment by Bayer AG also reduced equity by €2.2 billion. An increase of €0.7 billion – recognized outside profit or loss – came from the reduction in post-employment benefit obligations. Effects of the reduction in the interest in Covestro recognized directly in equity and the deconsolidation of this company increased equity by €0.7 billion. The equity ratio (equity coverage of total assets) as of December 31, 2017, was 49.1% (2016: 38.8%). Liabilities as of December 31, 2017, decreased by €12.1 billion to €38.2 billion. As part of the deconsolidation of Covestro, liabilities of €6.0 billion were derecognized in the corresponding line items in the statements of financial position. Provisions for pensions and other post-employment benefits decreased to €8.0 billion, with €1.2 billion of this due to the deconsolidation of Covestro, a further €1.2 billion to actuarial gains and €0.5 billion to the transfer of Covestro shares to Bayer Pension Trust e.V. Financial liabilities declined by €5.2 billion to €14.4 billion, with a reduction of €1.8 billion due to the deconsolidation of Covestro.